170 related articles for article (PubMed ID: 35795328)
1. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma.
Kuo YH; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Lu JC; Li CF
Onco Targets Ther; 2022; 15():727-740. PubMed ID: 35795328
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.
Kuo YH; Chan TC; Lai HY; Chen TJ; Wu LC; Hsing CH; Li CF
Front Oncol; 2021; 11():749142. PubMed ID: 34589439
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma.
Li WM; Chan TC; Huang SK; Wu WJ; Ke HL; Liang PI; Wei YC; Shiue YL; Li CF
Front Oncol; 2020; 10():570340. PubMed ID: 33194662
[No Abstract] [Full Text] [Related]
4. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
[No Abstract] [Full Text] [Related]
5. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
6. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
[TBL] [Abstract][Full Text] [Related]
7. High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
Li WM; Ke HL; Kuo YH; Lai HY; Chan TC; Hsing CH; Hsieh KL; Li WS; Chen TJ; Wei YC; Wu WJ; Huang SK; Li CF
Oncology; 2022; 100(9):485-497. PubMed ID: 35817020
[No Abstract] [Full Text] [Related]
8. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract][Full Text] [Related]
9. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
10. CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.
Lee YY; Wu WJ; Huang CN; Li CC; Li WM; Yeh BW; Liang PI; Wu TF; Li CF
J Cancer; 2016; 7(6):711-21. PubMed ID: 27076853
[TBL] [Abstract][Full Text] [Related]
11. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
[TBL] [Abstract][Full Text] [Related]
12. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
[TBL] [Abstract][Full Text] [Related]
13. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
[TBL] [Abstract][Full Text] [Related]
14. High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis.
Lai HY; Chiu CC; Kuo YH; Tsai HH; Wu LC; Tseng WH; Liu CL; Hsing CH; Huang SK; Li CF
Front Oncol; 2022; 12():834249. PubMed ID: 35372028
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis.
Li WM; Chan TC; Wei YC; Li CF; Ke HL; Wu WJ; Hsu CC; Wang SC; Yeh CF
Front Biosci (Landmark Ed); 2023 Sep; 28(9):217. PubMed ID: 37796703
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
[TBL] [Abstract][Full Text] [Related]
17. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
[TBL] [Abstract][Full Text] [Related]
18. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.
Mir MA; Pandith AA; Mansoor S; Baba SM; Makhdoomi R; Ain QU; Anwar I; Para SA; Bhat AH; Koul AM; Manzoor U; Khan I; Beg A; Wani MS
Gene; 2023 Aug; 878():147583. PubMed ID: 37353040
[TBL] [Abstract][Full Text] [Related]
20. High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas.
Chan TC; Li CF; Ke HL; Wei YC; Shiue YL; Li CC; Yeh HC; Lee HY; Huang SK; Wu WJ; Li WM
Urol Oncol; 2019 Apr; 37(4):293.e11-293.e24. PubMed ID: 30595463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
